CEL-SCI has begun enrolling patients from Sri Lanka for a Phase III trial for Multikine, an investigational treatment for head and neck cancer.
By linking Queensland records of HPV vaccinations with the pap smear register, scientists have been able to show that vaccinations have been effective in protecting against cervical cancer.
At the Global Young Scientists Summit 2014, a panel of distinguished scientists discussed how research should be driven by curiosity, not money.
At the Global Young Scientists Summit 2014, Nobel Laureate Harald zur Hausen discusses the link between high consumption of red meat and colorectal cancer.
Biocon and Advaxis will co-develop and commercialize ADXS-HPV, a novel cancer immunotherapy for the treatment of HPV.
An Australian biomedical engineer, Mark Kendall, has won the 2012 Rolex Awards for changing the way life-saving vaccines are delivered.